Mario Medical Co., Ltd. was founded in 2013. Initially starting with the development and sales of patented hyaluronic acid products, the company has now grown into the world’s leading botulinum toxin (Botox) brand by sales volume. With annual revenues exceeding 100 billion KRW, Mario Medical is headquartered in Seoul, South Korea, and has subsidiaries in Vietnam 🇻🇳, Malaysia 🇲🇾, Singapore 🇸🇬, and Thailand 🇹🇭. The company exports to 36 countries worldwide and has served customers from over 10+ countries, aiming to become the "Amazon of the medical aesthetics industry."

Currently, Mario Medical holds 15-30 exclusive brands and monopoly-tier distribution rights for premium products. The company’s mission is: "To promote the finest Korean-quality medical aesthetic products and deliver them to global customers worldwide." 🌍